Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO

被引：0
|
作者：
Marschner, N.
Potthoff, K. [1 ]
Salat, C.
Soeling, U.
Hansen, R.
Grebhardt, S. [1 ]
Horde, J. [1 ]
Nusch, A.
机构：
[1] iOMEDICO AG, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P598
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: final results of the non-interventional study NABUCCO
    Potthoff, K.
    Nusch, A.
    Soeling, U.
    Hansen, R.
    Salat, C.
    Grebhardt, S.
    Marschner, N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] 705 patients with metastatic breast cancer treated with nab-paclitaxel: Results of the non-interventional study NABUCCO
    Potthoff, K.
    Nusch, A.
    Soeling, U.
    Hansen, R.
    Salat, C.
    Grebhardt, S.
    Harde, J.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 33 - 34
  • [3] Overall survival and quality of life in patients with metastatic breast cancer treated with nab-paclitaxel: Final results of the non-interventional study NABUCCO
    Potthoff, K.
    Nusch, A.
    Soeling, U.
    Hansen, R.
    Salat, C.
    Grebhardt, S.
    Harde, J.
    Marschner, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] Safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer: a prospective, multicenter non-interventional study
    Steger, G.
    Petru, E.
    Haslbauer, F.
    Egle, D.
    Galid, A.
    Sliwa, T.
    Lang, A.
    Kuehr, T.
    Petzer, A.
    Ruckser, R.
    Mlineritsch, B.
    Greil, R.
    Seifert, M.
    Singer, C.
    Andel, J.
    Kwasny, W.
    Marth, C.
    Pichler, P.
    Tinchon, C.
    Bartsch, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study
    Adamo, V.
    Ricciardi, G.
    Schifano, S.
    Russo, A.
    Gebbia, V.
    Blasi, L.
    Giuffrida, D.
    Scandurra, G.
    Savarino, A.
    Butera, A.
    Borsellino, N.
    Verderame, F.
    Caruso, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Routine clinical use of nab-paclitaxel for advanced / metastatic breast cancer in Germany: Final results of the prospective observational study NABUCCO.
    Schroeder, Jan
    Potthoff, Karin
    Salat, Christoph
    Soeling, Ulrike
    Hansen, Richard
    Grebhardt, Sina
    Harde, Johanna
    Nusch, Arnd
    Marschner, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer
    Vishnu, Prakash
    Roy, Vivek
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 53 - 65
  • [8] Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel
    Marschner, Norbert
    Salat, Christoph
    Soeling, Ulrike
    Hansen, Richard
    Grebhardt, Sina
    Harde, Johanna
    Nusch, Arnd
    Potthoff, Karin
    CLINICAL BREAST CANCER, 2018, 18 (06) : E1323 - E1337
  • [9] Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine
    Eisterer, W.
    Gerger, A.
    Oehler, L.
    Mlineritsch, B.
    Sliwa, T.
    Wilthoner, K.
    Petzer, A.
    Pichler, P.
    Hubmann, E.
    Winder, T.
    Burgstaller, S.
    Korger, M.
    Andel, J.
    Woell, E.
    Neumann, H.
    Pecherstorfer, M.
    Philipp-Abbrederis, K.
    Djanani, A.
    Gruenberger, B.
    Laengle, F.
    Prager, G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
    Yamamoto, Yutaka
    Kawano, Ichiro
    Iwase, Hirotaka
    ONCOTARGETS AND THERAPY, 2011, 4 : 123 - 136
12345